FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Silva Francisco 2. Issuer Name and Ticker or Trading Symbol BioRestorative Therapies, Inc. [ BRTX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
VP of Research and Development
(Last)         (First)         (Middle)
40 MARCUS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)
11/23/2020
(Street)
MELVILLE, NY 11747
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/23/2020    J(12)    8375671  A  (12) 8431629  D   
Common Stock                 12116  I  IRA 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option  $.75                   (1) 4/4/2021  Common Stock  4000    4000  D   
Stock Option  $.75                  6/24/2011  6/23/2021  Common Stock  150    150  D   
Stock Option  $.75                  11/16/2011  11/15/2021  Common Stock  1000    1000  D   
Stock Option  $.75                   (2) 2/9/2022  Common Stock  2000    2000  D   
Stock Option  $.75                   (3) 5/2/2022  Common Stock  5500    5500  D   
Stock Option  $.75                   (4) 12/7/2022  Common Stock  4000    4000  D   
Stock Option  $.75                   (5) 10/4/2023  Common Stock  5000    5000  D   
Stock Option  $.75                   (6) 2/18/2024  Common Stock  12500    12500  D   
Stock Option  $.75                  3/12/2014  3/11/2024  Common Stock  2000    2000  D   
Stock Option  $.75                  4/14/2014  5/2/2022  Common Stock  2000    2000  D   
Stock Option  $.75                   (7) 10/23/2024  Common Stock  37500    37500  D   
Stock Option  $.75                   (8) 9/4/2025  Common Stock  25000    25000  D   
Stock Option  $.75                   (9) 6/10/2026  Common Stock  60000    60000  D   
Stock Option  $.75                   (10) 7/12/2027  Common Stock  80000    80000  D   
Stock Option  $.75                   (11) 10/29/2028  Common Stock  100000    100000  D   

Explanation of Responses:
(1)  The option is exercisable to the extent of 2,000 shares on each of April 5, 2011 and April 5, 2012.
(2)  The option is exercisable to the extent of 1,000 shares on each of February 10, 2012 and February 10, 2013.
(3)  The option is exercisable to the extent of 500 shares on each of May 3, 2013, May 3, 2014 and May 3, 2015, became exercisable to the extent of 1,000 shares based on the satisfaction of certain conditions and is exercisable to the extent of 3,000 shares subject to the satisfaction of certain conditions.
(4)  The option is exercisable to the extent of 2,000 shares on each of December 7, 2012 and December 7, 2013.
(5)  The option is exercisable to the extent of 2,500 shares on each of October 4, 2013 and October 4, 2014.
(6)  The option is exercisable to the extent of 4,167 shares on each of February 18, 2014 and February 18, 2015, and 4,166 shares on February 18, 2016.
(7)  The option is exercisable to the extent of 12,500 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
(8)  The option is exercisable to the extent of 8,334 shares on September 4, 2016 and 8,333 shares on each of September 4, 2017 and September 4, 2018.
(9)  The option is exercisable to the extent of 20,000 shares on each of June 10, 2017, June 10, 2018 and June 10, 2019.
(10)  The option is exercisable to the extent of 26,667 shares on each of July 12, 2018 and July 12, 2019, and 26,666 shares on July 12, 2020.
(11)  The option is exercisable to the extent of 33,334 shares on October 29, 2019, and 33,333 shares on each of October 29, 2020 and October 29, 2021.
(12)  Shares acquired from Issuer pursuant to amended joint plan of reorganization of Issuer (the "Plan"). Pursuant to the Plan, 100 shares of common stock were issued for each dollar of allowed unsecured claim.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Silva Francisco
40 MARCUS DRIVE
MELVILLE, NY 11747
X
VP of Research and Development

Signatures
/s/ Francisco Silva 11/23/2020
**Signature of Reporting Person Date
BioRestorative Therapies (PK) (USOTC:BRTX)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more BioRestorative Therapies (PK) Charts.
BioRestorative Therapies (PK) (USOTC:BRTX)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more BioRestorative Therapies (PK) Charts.